Cboe Global Markets, a publicly owned company founded in 1973 and headquartered in the US, employs approximately 1230 people. The company's holdings include the Chicago Board Options Exchange and BATS Global Markets, both of which operate stock exchanges.
On September 19, 2025, Onco-Innovations Limited announced that Dalton Pharma Services began manufacturing its PEO-b-PBz-CL 1 nanoparticle formulation, a key component of its drug delivery platform designed for use with its Polynucleotide Kinase Phosphatase (PNKP) inhibitor. Also on September 19, 2025, news emerged that Citigroup hired Adam Inzirillo from Cboe Global Markets to lead its cash and futures execution platform within the bank's equities division. A separate report from September 19, 2025, details a week-long engagement with retail traders, highlighting the enthusiasm within the retail trading community.
Subscribe for full access to Cboe Global Markets's products in full detail
Subscribe for full access to Cboe Global Markets's revenue in full detail
Subscribe for full access to Cboe Global Markets's products in full detail 
